Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Fig. 1

suPAR as an early predictor of the development of severe respiratory failure (SRF). a Admission levels of suPAR among Greek patients who eventually developed or not SRF. The p value of comparisons by the Mann-Whitney U test is provided. b Levels of suPAR in patients with COVID-19 and controls. The p value of comparisons by the Mann-Whitney U test is provided. c Time to SRF of Greek patients in relation to the admission levels of suPAR. CI, confidence interval; HR, hazard ratio

Back to article page

Critical Care

ISSN: 1364-8535